Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Michael M. Rowe | Chief Executive Officer | 2024-08-28 | 27,071 | $0.52 | $14.08kBuy |
Michael M. Rowe | Chief Executive Officer | 2024-08-26 | 50,000 | $0.57 | $28.50kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Stuart M. Grant | 378.59% | 10,914,153 | $156.73M | Insider |
Shuhei Yoshida | 60.77% | 1,751,900 | $25.16M | Insider |
Senju Pharmaceutical Co Ltd | 59.61% | 1,718,566 | $24.68M | Insider |
Fredric N. Eshelman | 56.15% | 1,618,835 | $23.25M | Insider |
Curt H. Labelle | 22.51% | 648,903 | $9.32M | Insider |
Ernest Mario | 13.28% | 382,706 | $5.50M | Insider |
Ubs Group Ag | 6.91% | 199,320 | $2.86M | Institution |
Michael M. Rowe | 3.82% | 109,998 | $1.58M | Insider |
Jennifer G. Clasby | 2.31% | 66,537 | $955.47k | Insider |
Kenneth B. Lee Jr. | 2.24% | 64,544 | $926.85k | Insider |